Siniša Popov is an External Quality professional at MSD Switzerland and a PhD candidate at the Faculty of Pharmacy Novi Sad, University Business Academy, Serbia. His research focuses on formulation and molecular modelling of biologics, including freeze-drying, subcutaneous delivery of monoclonal antibodies and mRNA-LNP systems, peptide and protein stability, excipient interactions, and molecular dynamics simulations. He is also the founder of Helvetia Tech Solutions, where he is developing BioXion, an AI-driven biopharma development intelligence platform, and FormulytiX, a formulation intelligence platform for predictive development of biologics.
Siniša Popov is an External Quality professional at MSD Switzerland and a PhD candidate at the Faculty of Pharmacy Novi Sad, University Business Academy, Serbia. His research focuses on formulation and molecular modelling of biologics, including freeze-drying, subcutaneous delivery of monoclonal antibodies and mRNA-LNP systems, peptide and protein stability, excipient interactions, and molecular dynamics simulations. He is also the founder of Helvetia Tech Solutions, where he is developing BioXion, an AI-driven biopharma development intelligence platform, and FormulytiX, a formulation intelligence platform for predictive development of biologics.